Gerald C Wallace - JoVE Visualize

Showing results (1-10 of 10) with videos related to

Pageof 1

Sort By:

Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 17, 2026

Adverse effects associated with intrathecal chemotherapy for leptomeningeal diseaseLauren Martin, Campbell Scott, Gerald C Wallace

Current Treatment Options in Oncology|July 2, 2021

Precision Therapy for Brain Tumors in Hereditary SyndromesGerald C Wallace, Madeleine Tjoelker, Kaitlyn Bartley, et al.

Frontiers in Oncology|February 9, 2026

Brain metastases from non-small cell lung cancer: molecular subtypes and emerging CNS-directed precision therapiesMehek Sharma, Anvay Shah, Kimberly A Rivera-Caraballo, et al.

Journal of Neuroscience Research|July 13, 2010

Calpeptin attenuated inflammation, cell death, and axonal damage in animal model of multiple sclerosisM Kelly Guyton, Arabinda Das, Supriti Samantaray, et al.

Surgical Neurology International|May 12, 2025

Presentation of extranodal NK/T-cell lymphoma as a pituitary mass: A case report and review of the literatureMolly Butler, Christopher Carr, Mehul Mehra, et al.

Neurochemical Research|January 10, 2012

Drug resistance in glioblastoma: a mini reviewCatherine P Haar, Preetha Hebbar, Gerald C Wallace, et al.

Metabolic Brain Disease|April 2, 2013

Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastomaGerald C Wallace, Yaenette N Dixon-Mah, W Alex Vandergrift, et al.

Journal of Neuro-Oncology|June 12, 2013

Multi-targeted DATS prevents tumor progression and promotes apoptosis in ectopic glioblastoma xenografts in SCID mice via HDAC inhibitionGerald C Wallace, Catherine P Haar, W Alex Vandergrift, et al.

Cancer Chemotherapy and Pharmacology|September 14, 2018

Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastomaArabinda Das, Fraser Henderson, Stephen Lowe, et al.

Biorxiv : the Preprint Server for Biology|January 8, 2024

Branched-chain keto acids promote an immune-suppressive and neurodegenerative microenvironment in leptomeningeal diseaseMariam Lotfy Khaled, Yuan Ren, Ronak Kundalia, et al.

Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:

Pageof 1

Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 17, 2026

Adverse effects associated with intrathecal chemotherapy for leptomeningeal diseaseLauren Martin, Campbell Scott, Gerald C Wallace

Current Treatment Options in Oncology|July 2, 2021

Precision Therapy for Brain Tumors in Hereditary SyndromesGerald C Wallace, Madeleine Tjoelker, Kaitlyn Bartley, et al.

Frontiers in Oncology|February 9, 2026

Brain metastases from non-small cell lung cancer: molecular subtypes and emerging CNS-directed precision therapiesMehek Sharma, Anvay Shah, Kimberly A Rivera-Caraballo, et al.

Journal of Neuroscience Research|July 13, 2010

Calpeptin attenuated inflammation, cell death, and axonal damage in animal model of multiple sclerosisM Kelly Guyton, Arabinda Das, Supriti Samantaray, et al.

Surgical Neurology International|May 12, 2025

Presentation of extranodal NK/T-cell lymphoma as a pituitary mass: A case report and review of the literatureMolly Butler, Christopher Carr, Mehul Mehra, et al.

Neurochemical Research|January 10, 2012

Drug resistance in glioblastoma: a mini reviewCatherine P Haar, Preetha Hebbar, Gerald C Wallace, et al.

Metabolic Brain Disease|April 2, 2013

Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastomaGerald C Wallace, Yaenette N Dixon-Mah, W Alex Vandergrift, et al.

Journal of Neuro-Oncology|June 12, 2013

Multi-targeted DATS prevents tumor progression and promotes apoptosis in ectopic glioblastoma xenografts in SCID mice via HDAC inhibitionGerald C Wallace, Catherine P Haar, W Alex Vandergrift, et al.

Cancer Chemotherapy and Pharmacology|September 14, 2018

Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastomaArabinda Das, Fraser Henderson, Stephen Lowe, et al.

Biorxiv : the Preprint Server for Biology|January 8, 2024

Branched-chain keto acids promote an immune-suppressive and neurodegenerative microenvironment in leptomeningeal diseaseMariam Lotfy Khaled, Yuan Ren, Ronak Kundalia, et al.

Pageof 1